1. Home
  2. CGTX vs XIN Comparison

CGTX vs XIN Comparison

Compare CGTX & XIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CGTX
  • XIN
  • Stock Information
  • Founded
  • CGTX 2007
  • XIN 1997
  • Country
  • CGTX United States
  • XIN China
  • Employees
  • CGTX N/A
  • XIN N/A
  • Industry
  • CGTX Biotechnology: Pharmaceutical Preparations
  • XIN Homebuilding
  • Sector
  • CGTX Health Care
  • XIN Consumer Discretionary
  • Exchange
  • CGTX Nasdaq
  • XIN Nasdaq
  • Market Cap
  • CGTX 17.9M
  • XIN 16.2M
  • IPO Year
  • CGTX 2021
  • XIN N/A
  • Fundamental
  • Price
  • CGTX $0.43
  • XIN $2.84
  • Analyst Decision
  • CGTX Strong Buy
  • XIN
  • Analyst Count
  • CGTX 6
  • XIN 0
  • Target Price
  • CGTX $8.30
  • XIN N/A
  • AVG Volume (30 Days)
  • CGTX 2.8M
  • XIN 21.5K
  • Earning Date
  • CGTX 05-06-2025
  • XIN 01-01-0001
  • Dividend Yield
  • CGTX N/A
  • XIN N/A
  • EPS Growth
  • CGTX N/A
  • XIN N/A
  • EPS
  • CGTX N/A
  • XIN N/A
  • Revenue
  • CGTX N/A
  • XIN $667,143,185.00
  • Revenue This Year
  • CGTX N/A
  • XIN N/A
  • Revenue Next Year
  • CGTX N/A
  • XIN N/A
  • P/E Ratio
  • CGTX N/A
  • XIN $0.32
  • Revenue Growth
  • CGTX N/A
  • XIN N/A
  • 52 Week Low
  • CGTX $0.34
  • XIN $2.24
  • 52 Week High
  • CGTX $2.95
  • XIN $7.05
  • Technical
  • Relative Strength Index (RSI)
  • CGTX 27.35
  • XIN 49.99
  • Support Level
  • CGTX $0.36
  • XIN $2.68
  • Resistance Level
  • CGTX $0.45
  • XIN $3.00
  • Average True Range (ATR)
  • CGTX 0.05
  • XIN 0.21
  • MACD
  • CGTX -0.01
  • XIN -0.01
  • Stochastic Oscillator
  • CGTX 23.66
  • XIN 28.57

About CGTX Cognition Therapeutics Inc.

Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.

About XIN Xinyuan Real Estate Co Ltd

Xinyuan Real Estate Co Ltd operates as a real estate developer and property manager in China. It focuses on developing residential projects, which typically consist of multiple residential buildings that include multi-layer apartment buildings, and others. Its several projects include auxiliary services and amenities such as retail outlets, leisure and health facilities, kindergartens, and schools. It aims to provide comfortable and convenient real estate-related products and services to middle-class consumers.

Share on Social Networks: